mFolfirinox-Bevacizumab Regimen

Preferred Label : mFolfirinox-Bevacizumab Regimen;

NCIt synonyms : mFolfirinox-Avastin; mFolfirinox Plus Bevacizumab; mFolfirinox/Bevacizumab; mFolfirinox-Bevacizumab; Bevacizumab-mFolfirinox; Bevacizumab Plus mFolfirinox; Modified Folfirinox-Bevacizumab;

NCIt definition : A modified, dose-adjusted regimen consisting of fluorouracil, leucovorin, oxaliplatin and irinotecan (mFOLFIRINOX), and bevacizumab that may be used for the treatment of appendiceal adenocarcinoma, colorectal cancer, and small bowel adenocarcinoma.;

NCI Metathesaurus CUI : CL1905342;

Details

Origin ID

C192057;

UMLS CUI

C5781392;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Fluorouracil [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
- Leucovorin Calcium [NCIt concept]
- Oxaliplatin [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients